Cargando…
Eligibility for icosapent ethyl in a French population of coronary outpatients with type 2 diabetes
INTRODUCTION: We determined eligibility for icosapent ethyl (EPA) treatment in coronary artery disease (CAD). METHODS: Consecutive patients with type 2 diabetes and CAD were prospectively included from 03/2019 to 12/2020. RESULTS: 574 patients were included; mean age 71 years, 81% males, with a high...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696963/ http://dx.doi.org/10.5114/aoms/173511 |